TP53 and neoplasm: Our findings demonstrate how p53, in conjunction with miR-34c, orchestrates the dual induction of ferroptosis and apoptosis while simultaneously suppressing drug resistance mechanisms, revealing a finely tuned balance critical for tumor suppression.